Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Ferric carboxymaltose effectively improved iron deficiency anemia symptoms and increased hemoglobin and ferritin levels.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Skin cells from people with Epidermolysis Bullosa Simplex have abnormally placed and less active mitochondria.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Applying InlB321/15 to wounds sped up healing in mice.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Bicalutamide may help treat female pattern hair loss.

Lef1 helps stem cells become hair cells by interacting with specific signaling pathways.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

Biofibre hair implant is a safe, effective treatment for baldness with 95% patient satisfaction.

Hair follicle cells produce VEGF, which can promote blood vessel cell growth and movement.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

M50054 may help treat hepatitis and hair loss from chemotherapy.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.